“Lipofectamine-Mediated CRISPR-Cas9 Delivery Targeting the MecA Gene in Methicillin-Resistant Staphylococcus Aureus: A Novel Approach to Reverse Antibiotic Resistance”. Wah Academia Journal of Health and Nutrition, vol. 2, no. 2, June 2026, pp. 27-35, https://doi.org/10.63954/bantev40.